These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 35098436)
21. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality. van Nijnatten TJA; Jochelson MS; Lobbes MBI Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513 [TBL] [Abstract][Full Text] [Related]
23. Wu J; Tian J; Zhang Y; Ji H; Sun J; Wang X; Sun C; Wang L; Teng Z; Lu G; Zhu H; Chen X Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2869-2876. PubMed ID: 35138445 [TBL] [Abstract][Full Text] [Related]
24. COVID-19 Vaccination Manifesting as Incidental Lymph Nodal Uptake on 18F-FDG PET/CT. Ahmed N; Muzaffar S; Binns C; Ilyas MW; Usmani S Clin Nucl Med; 2021 May; 46(5):435-436. PubMed ID: 33661193 [TBL] [Abstract][Full Text] [Related]
25. The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients. Choi WH; Yoo IR; O JH; Kim SH; Chung SK Br J Radiol; 2011 Jul; 84(1003):593-9. PubMed ID: 21081574 [TBL] [Abstract][Full Text] [Related]
26. Morphological and Metabolic Criteria of COVID-19 Vaccine Associated Axillary Nodes on 18-Fluorodeouxyglucose PET/CT Imaging in Breast Cancer Patients. Fatima N; Zaman U; Zaman A; Zaman S; Tahseen R; Zaman MU Asian Pac J Cancer Prev; 2023 Dec; 24(12):4053-4057. PubMed ID: 38156837 [TBL] [Abstract][Full Text] [Related]
33. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. Ueda S; Tsuda H; Asakawa H; Omata J; Fukatsu K; Kondo N; Kondo T; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H BMC Cancer; 2008 Jun; 8():165. PubMed ID: 18541009 [TBL] [Abstract][Full Text] [Related]
34. Lessons Learned from Post-COVID-19 Vaccination PET/CT Studies. Orevi M; Chicheportiche A; Ben Haim S J Nucl Med; 2022 Mar; 63(3):453-460. PubMed ID: 34301777 [TBL] [Abstract][Full Text] [Related]
35. Metabolic and volume-based parameters of (18F)FDG PET/CT for primary mass and axillary lymph node metastasis in patients with invasive ductal carcinoma: a retrospective analysis in relation to molecular subtype, axillary lymph node metastasis and immunohistochemistry and inflammatory markers. Can C; Komek H Nucl Med Commun; 2019 Oct; 40(10):1051-1059. PubMed ID: 31365497 [TBL] [Abstract][Full Text] [Related]
37. Predictive value of primary tumor parameters using Yoo J; Kim BS; Yoon HJ Ann Nucl Med; 2018 Nov; 32(9):642-648. PubMed ID: 30094546 [TBL] [Abstract][Full Text] [Related]
38. Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines. Adin ME; Isufi E; Wu J; Pang Y; Nguyen D; Simsek Has D; Caner C; Aboueldaha N; Mossa-Basha M; Pucar D Nucl Med Commun; 2024 Jun; 45(6):474-480. PubMed ID: 38465449 [TBL] [Abstract][Full Text] [Related]
39. The clinical value of tumor FDG uptake for predicting axillary lymph node metastasis in breast cancer with clinically negative axillary lymph nodes. Seok JW; Kim Y; An YS; Kim BS Ann Nucl Med; 2013 Jul; 27(6):546-53. PubMed ID: 23543486 [TBL] [Abstract][Full Text] [Related]
40. Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on Chiang MT; Wang JT; Lin WY; Yen RF; Huang JY; Lu CC Eur J Med Res; 2023 Nov; 28(1):513. PubMed ID: 37964395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]